The clinical implications of medulloblastoma subgroups.

Nature Reviews. Neurology
Paul A NorthcottMichael D Taylor

Abstract

Medulloblastoma, the most common malignant paediatric brain tumour, is currently diagnosed and stratified using a combination of clinical and demographic variables. Recent transcriptomic approaches have demonstrated that the histological entity known as medulloblastoma is comprised of multiple clinically and molecularly distinct subgroups. The current consensus is that four defined subgroups of medulloblastoma exist: WNT, SHH, Group 3, and Group 4. Each subgroup probably contains at least one additional level of hierarchy, with some evidence for multiple subtypes within each subgroup. The demographic and clinical differences between the subgroups present immediate and pressing questions to be addressed in the next round of clinical trials for patients with medulloblastoma. Many of the genetically defined targets for rational medulloblastoma therapies are unique to a given subgroup, suggesting the need for subgroup-specific trials of novel therapies. The development of practical, robust and widely accepted subgroup biomarkers that are amenable to the conditions of a prospective clinical trial is, therefore, an urgent need for the paediatric neuro-oncology community. In this Review, we discuss the clinical implications of molecul...Continue Reading

References

Mar 30, 1995·The New England Journal of Medicine·S R HamiltonB Tetu
Jun 1, 1994·Journal of Neurosurgery·D L JohnsonG Reaman
Jan 1, 1995·Journal of Neuro-oncology·L B RorkeJ Biegel
Apr 17, 1999·Brain & Development·R J Packer
Mar 31, 2000·American Journal of Human Genetics·M D TaylorJ T Rutka
Apr 3, 2001·Annual Review of Neuroscience·R Wechsler-Reya, M P Scott
Jun 18, 2002·Nature Genetics·Michael D TaylorDavid Hogg
Aug 2, 2002·Cancer Cell·Joshua B Rubin, David H Rowitch
Sep 5, 2002·International Journal of Cancer. Journal International Du Cancer·Naoki YokotaMasato Maekawa
Jul 8, 2003·Pediatric Neurosurgery·Roger J PackerTobey J MacDonald
Sep 10, 2003·Journal of Neurosurgery·Paul C ParkJames T Rutka
Feb 19, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul Graham FisherCharles G Eberhart
Apr 13, 2004·Oncogene·Michael D TaylorJames T Rutka
Jun 17, 2004·Journal of Neuropathology and Experimental Neurology·Charles G EberhartPeter C Burger
Nov 19, 2004·Nature·Sheila K SinghPeter B Dirks
Jan 28, 2005·Journal of Neuro-oncology·Torsten PietschJames T Rutka
Mar 11, 2005·The New England Journal of Medicine·Stefan RutkowskiJoachim Kuehl
Mar 11, 2005·American Journal of Medical Genetics. Part a·David NgAlisa M Goldstein
Nov 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David W EllisonUNKNOWN United Kingdom Children's Cancer Study Group Brain Tumour Committee
Nov 8, 2005·Journal of Neurosurgery·Roger J Packer
Jan 21, 2006·Cancer Research·Duncan StearnsCharles G Eberhart
Feb 8, 2006·Journal of Neuropathology and Experimental Neurology·Talitha de HaasMarcel Kool
Mar 29, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Margaret C ThompsonRichard J Gilbertson
Aug 9, 2006·Expert Review of Neurotherapeutics·Stefan Rutkowski
Mar 29, 2007·Brain Pathology·Charles S McManamyUNKNOWN Clinical Brain Tumour Group
Nov 28, 2007·Annual Review of Pathology·Richard J Gilbertson, David W Ellison
Feb 19, 2008·Nature Biotechnology·Gary K GeissKrassen Dimitrov
Jun 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Xing Fan, Charles G Eberhart
Feb 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Tamar UzielMartine F Roussel
Mar 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stefan PfisterAndrey Korshunov

❮ Previous
Next ❯

Citations

Dec 12, 2012·Current Oncology Reports·Emma B Holliday, Erik P Sulman
Jul 27, 2012·Nature·Paul A NorthcottMichael D Taylor
Nov 24, 2012·Nature Reviews. Cancer·Paul A NorthcottStefan M Pfister
Aug 2, 2013·Japanese Journal of Clinical Oncology·Takahiro OikeTakashi Kohno
Nov 1, 2012·Neuro-oncology·Koichi IchimuraMasao Matsutani
May 15, 2013·Molecular and Cellular Biology·Jordi BerenguerSebastian Pons
Apr 17, 2013·BMC Biology·Tom J Carney, Philip W Ingham
Nov 21, 2013·Acta Neuropathologica Communications·Kelsey L WhittierM Sue O'Dorisio
Oct 23, 2012·Journal of Neurosurgery. Pediatrics·Eric M ThompsonEdward A Neuwelt
Feb 27, 2014·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Thora GudrunardottirRoger J Packer
May 17, 2014·AJNR. American Journal of Neuroradiology·S PerreaultK W Yeom
Jul 11, 2014·Cellular and Molecular Life Sciences : CMLS·Iva Simeonova, Emmanuelle Huillard
Feb 14, 2014·Journal of Radiation Research·Takahiro OikeTakashi Kohno
Nov 1, 2013·Acta Neuropathologica·Marc RemkeMichael D Taylor
Oct 29, 2014·Nature Reviews. Clinical Oncology·Amar J Gajjar, Giles W Robinson
Jun 2, 2015·Expert Review of Neurotherapeutics·Ayman SamkariRoger Packer
Jan 28, 2016·Nature·Charles Y LinPaul A Northcott
Jan 14, 2016·Nature·A Sorana MorrissyMichael D Taylor
Jan 16, 2016·Journal of Neurosurgery·Wenya Linda BiIan F Dunn
Oct 17, 2015·Journal of Neurosurgery. Pediatrics·Paul KlimoAsim F Choudhri
Dec 21, 2012·Pediatric Blood & Cancer·Amar GajjarUNKNOWN COG Brain Tumor Committee
Mar 20, 2016·Cellular and Molecular Neurobiology·Esterina D'AstiJanusz Rak
Jun 19, 2013·International Journal of Cancer. Journal International Du Cancer·Luis A MillaVerónica Palma
Jul 16, 2013·International Journal of Cancer. Journal International Du Cancer·Jeannine LacroixHendrik Witt
Mar 26, 2016·Neurosurgery Clinics of North America·Wenya Linda BiIan F Dunn
Mar 13, 2014·Pediatric Blood & Cancer·Vijay RamaswamyEric Bouffet
Mar 26, 2014·Pediatric Blood & Cancer·Roger J Packer
Mar 27, 2016·Brain Research·Pierre-Jean Le ResteEric Chevet
Nov 14, 2013·Experimental Hematology & Oncology·Wendy J IngramAndrew R Hallahan
Sep 12, 2015·Cytotechnology·Patrícia Benites Gonçalves da SilvaOswaldo Keith Okamoto
Sep 10, 2015·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Charles RaybaudSuzanne Laughlin
Feb 3, 2015·Archives of Pathology & Laboratory Medicine·Daniel J BratUNKNOWN Members of the Cancer Biomarker Reporting Committee, College of American Pathologists
Jul 16, 2013·Pediatric Hematology and Oncology·Kornelius KerlMichael C Frühwald
May 16, 2015·Seminars in Pediatric Neurology·Ayman SamkariRoger J Packer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved